» Articles » PMID: 26714629

Comparative Genomics and Biological Characterization of Sequential Pseudomonas Aeruginosa Isolates from Persistent Airways Infection

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2015 Dec 31
PMID 26714629
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pseudomonas aeruginosa establishes life-long chronic airway infections in cystic fibrosis (CF) patients. As the disease progresses, P. aeruginosa pathoadaptive variants are distinguished from the initially acquired strain. However, the genetic basis and the biology of host-bacteria interactions leading to a persistent lifestyle of P. aeruginosa are not understood. As a model system to study long term and persistent CF infections, the P. aeruginosa RP73, isolated 16.9 years after the onset of airways colonization from a CF patient, was investigated. Comparisons with strains RP1, isolated at the onset of the colonization, and clonal RP45, isolated 7 years before RP73 were carried out to better characterize genomic evolution of P. aeruginosa in the context of CF pathogenicity.

Results: Virulence assessments in disease animal model, genome sequencing and comparative genomics analysis were performed for clinical RP73, RP45, RP1 and prototype strains. In murine model, RP73 showed lower lethality and a remarkable capability of long-term persistence in chronic airways infection when compared to other strains. Pathological analysis of murine lungs confirmed advanced chronic pulmonary disease, inflammation and mucus secretory cells hyperplasia. Genomic analysis predicted twelve genomic islands in the RP73 genome, some of which distinguished RP73 from other prototype strains and corresponded to regions of genome plasticity. Further, comparative genomic analyses with sequential RP isolates showed signatures of pathoadaptive mutations in virulence factors potentially linked to the development of chronic infections in CF.

Conclusions: The genome plasticity of P. aeruginosa particularly in the RP73 strain strongly indicated that these alterations may form the genetic basis defining host-bacteria interactions leading to a persistent lifestyle in human lungs.

Citing Articles

Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model.

Pont S, Nilly F, Berry L, Bonhoure A, Alford M, Louis M PLoS Pathog. 2025; 21(2):e1012922.

PMID: 39946497 PMC: 11825101. DOI: 10.1371/journal.ppat.1012922.


Genomic and phenotypic characterization of isolates from two Mexican cystic fibrosis attention centers.

Nunez-Garcia L, Feliciano-Guzman J, Mireles-Davalos C, Lopez-Santiz J, Ovando-Fonseca J, Becerril-Vargas E Microbiol Spectr. 2024; :e0110024.

PMID: 39440985 PMC: 11619361. DOI: 10.1128/spectrum.01100-24.


in chronic lung disease: untangling the dysregulated host immune response.

Nickerson R, Thornton C, Johnston B, Lee A, Cheng Z Front Immunol. 2024; 15:1405376.

PMID: 39015565 PMC: 11250099. DOI: 10.3389/fimmu.2024.1405376.


Host-microbe interactions in chronic rhinosinusitis biofilms and models for investigation.

Vanderpool E, Rumbaugh K Biofilm. 2023; 6:100160.

PMID: 37928619 PMC: 10622848. DOI: 10.1016/j.bioflm.2023.100160.


The Antimicrobial, Antibiofilm and Anti-Inflammatory Activities of P13#1, a Cathelicidin-like Achiral Peptoid.

Cafaro V, Bosso A, Di Nardo I, DAmato A, Izzo I, De Riccardis F Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895857 PMC: 10610514. DOI: 10.3390/ph16101386.


References
1.
Smith E, Buckley D, Wu Z, Saenphimmachak C, Hoffman L, DArgenio D . Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A. 2006; 103(22):8487-92. PMC: 1482519. DOI: 10.1073/pnas.0602138103. View

2.
Diggle S, Cornelis P, Williams P, Camara M . 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol. 2006; 296(2-3):83-91. DOI: 10.1016/j.ijmm.2006.01.038. View

3.
Tang H, DiMango E, Bryan R, Gambello M, Iglewski B, Goldberg J . Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun. 1996; 64(1):37-43. PMC: 173724. DOI: 10.1128/iai.64.1.37-43.1996. View

4.
Lyczak J, Cannon C, Pier G . Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000; 2(9):1051-60. DOI: 10.1016/s1286-4579(00)01259-4. View

5.
Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer K . Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002; 109(3):317-25. PMC: 150856. DOI: 10.1172/JCI13870. View